Murdo Gordon, executive vice president and chief commercial officer at Bristol-Myers Squibb (B-MS), will leave his post at the beginning of August.
Mr Gordon, who has been with B-MS for more than two decades, is leaving to take up an opportunity elsewhere. Neither his new role nor his replacement have been announced.
"On behalf of the company, I want to thank Murdo for his leadership and the important contributions he’s made in his many years with B-MS," said Giovanni Caforio, chairman and chief executive officer of the US pharma major.
"Murdo helped build a highly performing commercial organization and developed a strong bench of talent, contributing to our competitive position in the market and our success in delivering innovative medicines to patients."
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze